Benchmark Holdings Plc — Earnings Release 2021

May 18, 2021

Second Quarter and Interim results for the six months ended 31 March 2021

Second Quarter and Interim results for the six months ended 31 March 2021

Good performance in the first half of the year and strategic progress in all business areas

Benchmark (LSE: BMK), the aquaculture biotechnology company, announces its unaudited interim results for the six months ended 31 March 2021 (the “Period”). The Company also announces its unaudited results for the three months ended 31 March 2021 in compliance with the terms of its senior secured bond.

• Good H1 2021 performance with growth in revenues (+11% CER) and Adjusted EBITDA (+13% CER) reflecting a strong performance in Advanced Nutrition and solid trading in Genetics and Health

• Q2 2021 results reflect seasonal fluctuations in Genetics and a lower contribution from biological asset movements due to normalised biomass growth

• Significant progress towards commercialisation of BMK08 and CleanTreat® with first customer contracts and ratification of MRL (“Maximum Residue Level”) opinion achieved in Q2

• Positive outlook and trading in line with market expectations, with good visibility of revenues for the second half of the year